A significant implementation roadblock is the ownership battle between IT and business functions. IT wants to control infrastructure and moves slowly, taking years. In response, business units run their own unsanctioned initiatives to move quickly, leading to a disconnected and unscalable approach to AI.

Despite proven cost efficiencies from deploying fine-tuned AI models, companies report the primary barrier to adoption is human, not technical. The core challenge is overcoming employee inertia and successfully integrating new tools into existing workflows—a classic change management problem.

Companies believe AI isn't delivering because technology moves too fast, so they invest in training and agile frameworks. The real, invisible problems are structural: ambiguous decision rights, siloed data ownership, and misaligned employee incentives. Solving for 'speed' when the foundation is broken guarantees failure.

While AI's technical capabilities advance exponentially, widespread organizational adoption is slowed by human factors like resistance to change, lack of urgency, and abstract understanding. This creates a significant gap between potential and reality.

Companies run numerous disconnected AI pilots in R&D, commercial, and other silos, each with its own metrics. This fragmented approach prevents enterprise-wide impact and disconnects AI investment from C-suite goals like share price or revenue growth. The core problem is strategic, not technical.

Despite mature AI technology and strong executive desire for adoption, the primary bottleneck for enterprises is internal change management. The difficulty lies in getting organizations to fundamentally alter their established business processes and workflows, creating a disconnect between stated goals and actual implementation.

Despite AI's potential, large enterprises struggle to see bottom-line impact. The primary hurdle isn't the tech, but the human challenge of "change management"—overcoming bureaucracy and altering complex, undocumented workflows within large organizations.

The most significant hurdle for businesses adopting revenue-driving AI is often internal resistance from senior leaders. Their fear, lack of understanding, or refusal to experiment can hold the entire organization back from crucial innovation.

The primary barrier to successful AI implementation in pharma isn't technical; it's cultural. Scientists' inherent skepticism and resistance to new workflows lead to brilliant AI tools going unused. Overcoming this requires building 'informed trust' and effective change management.